Elsevier Inc.

SHERPA: Unknown

People

  1. Adusumilli
    Adusumilli
  2. Jones
    Jones
  3. Travis
    Travis
  4. Tan
    Tan
  5. Downey
    Downey
  6. Kris
    Kris
  7. Rekhtman
    Rekhtman
  8. Riely
    Riely
  9. Rudin
    Rudin
  10. Rusch
    Rusch

Groups

  1. Surgery (28)
  2. Sloan Kettering Institute Postdocs (24)
  3. Department of Medicine (21)
  4. Solid Tumor Oncology Division (20)
  5. Thoracic Oncology (18)
  6. Biostatistics Service (11)
  7. Epidemiology and Biostatistics (11)
  8. GSK Faculty (5)
  9. Radiation Oncology, Department of (5)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
Search Within
  1. "Meeting abstract"
  2. "2017"
  3. "Journal of Thoracic Oncology"
Formats
  1. Meeting Abstract (53)
Groups
  1. Surgery (28)
  2. Sloan Kettering Institute Postdocs (24)
  3. Department of Medicine (21)
  4. Solid Tumor Oncology Division (20)
  5. Thoracic Oncology (18)
  6. Biostatistics Service (11)

More Groups

People
  1. Prasad Adusumilli (24)
  2. Takashi Eguchi (19)
  3. David Jones (17)
  4. William Travis (15)
  5. Shaohua Lu (11)
  6. Kay See Tan (9)

More People

Years
  1. 2017 (53)
Publications
  1. Journal of Thoracic Oncology (53)

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lanreotide in patients with lung neuroendocrine tumors: The randomized double-blind placebo-controlled international phase 3 SPINET study
    Meeting Abstract

    Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Singh, S.; Ferone, D.; Hoersch, D.; Mirakhur, B.; Hoffmanns, P.; Houchard, A.; Caplin, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Comparability of the relative survival metrics among lung cancer patients and general population
    Meeting Abstract

    Tan, K. S.; Eguchi, T.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Appropriate endpoint for stage I NSCLC: Correlations of long-term survival with disease-free and recurrence-free survival
    Meeting Abstract

    Tan, K. S.; Eguchi, T.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets
    Meeting Abstract

    Hristov, B.; Eguchi, T.; Chintala, N.; Lu, S.; Bott, M.; Travis, W.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Preoperative needle biopsy and tumor spread through alveolar spaces (STAS) in resected lung adenocarcinomas
    Meeting Abstract

    Kameda, K.; Eguchi, T.; Lu, S.; Solomon, S.; Bott, M.; Jones, D.; Rekhtman, N.; Travis, W.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Minimally invasive lobectomy is associated with lower noncancer mortality in elderly: A propensity-score matched analysis
    Meeting Abstract

    Hristov, B.; Eguchi, T.; Isbell, J.; Park, B.; Tan, K. S.; Rusch, V.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A stem-cell oriented phylogeny of non-small cell lung cancers
    Meeting Abstract

    Downey, R.; Riester, M.; Wu, H. J.; Moreira, A.; Michor, F.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy
    Meeting Abstract

    Paik, P.; Stammberger, U.; Bruns, R.; Overton, L.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
    Meeting Abstract

    Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Safety, clinical activity and biomarker results from a phase lb study of erlotinib plus atezolizumab in advanced NSCLC
    Meeting Abstract

    Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save